RETRACTION: Bioactive injectable triple acting thermosensitive hydrogel enriched with nano-hydroxyapatite for bone regeneration: in-vitro characterization, Saos-2 cell line cell viability and osteogenic markers evaluation (vol 45, pg 787, 2019) (Retraction of Vol 45, Pg 787, 2019)

被引：0

|

作者：

不详

机构：

来源：

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 2023年 / 48卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

收藏

页码：746 / 746

页数：1

相关论文

共 2 条

[1] RETRACTION: Bioactive injectable triple acting thermosensitive hydrogel enriched with nano-hydroxyapatite for bone regeneration: in-vitro characterization, Saos-2 cell line cell viability and osteogenic markers evaluation (Vol 45, pg 787, 2019) (Retraction of Vol 45, Pg 787, 2019)
Morsi, Nadia M.
Shamma, Rehab Nabil
Eladawy, Nouran Osama
Abdelkhalek, Abdelfattah A.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023,
[2] RETRACTED: Bioactive injectable triple acting thermosensitive hydrogel enriched with nano-hydroxyapatite for bone regeneration: in-vitro characterization, Saos-2 cell line cell viability and osteogenic markers evaluation (Retracted article. See JAN, 2023)
Morsi, Nadia M.
Shamma, Rehab Nabil
Eladawy, Nouran Osama
Abdelkhalek, Abdelfattah A.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (05) : 787 - 804